Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Change in Directorate

Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Underperformer

992.3000 -1.20 (-0.12%)

NSE Jun 17, 2025 12:09 PM

27.04% Fall from 52W High

Volume: 37,415

Cohance Lifesciences Ltd.

29 Sep 2023

992.30

-0.12%

Company Update

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

Outcome of the board meeting - Change in directors of the company

More from Cohance Lifesciences Ltd.

Recommended

Market trades lower, Axiscades signs an MoU with Indra to develop defence solutions in India

Trendlyne Marketwatch | 17 Jun 2025, 11:46AM

Chart of the Week: FIIs raise bets in consumer-driven sectors over the year

The Baseline | 16 Jun 2025, 05:21PM

IPOs This Week: Oswal Pumps and Three Others to List; Arisinfra Plus Five New Issues

| 16 Jun 2025, 05:10PM